Кардиоваскулярная терапия и профилактика (Aug 2013)

EXPERT CONSENSUS. ROLE OF COMBINATION LIPID-LOWERING THERAPY (SIMVASTATIN/EZETIMIBE 20/10 MG) IN THE CORRECTION OF LIPID METABOLISM DISTURBANCES IN PATIENTS WITH CHRONIC KIDNEY DISEASE

  • A. Catapano,
  • E. V. Shlyakhto,
  • A. I. Martynov,
  • R. G. Oganov,
  • V. V. Kukharchuk,
  • M. V. Shestakova,
  • A. S. Ametov,
  • S. A. Boicov,
  • M. G. Bubnova,
  • S. V. Villevalde,
  • A. S. Galyavich,
  • Yu. A. Karpov,
  • J. D. Kobalava,
  • O. N. Koziolova

DOI
https://doi.org/10.15829/1728-8800-2013-4-75-78
Journal volume & issue
Vol. 12, no. 4
pp. 75 – 78

Abstract

Read online

Expert Consensus. Role of combination lipid-lowering therapy (simvastatin/ezetimibe 20/10 mg) in the correction of lipid metabolism disturbances in patients with chronic kidney disease.